| Stock | Dividend Yield | P/E Ratio | Dividend Frequency |
Years Paying |
DGR |
|
LLY Lilly(Eli) & Co
Challengers
|
1.30% |
36.45
|
4 |
50 |
10%
|
|
JNJ Johnson & Johnson
Champions
|
2.35% |
30.42
|
4 |
60 |
6%
|
|
GWPH GW Pharmaceuticals plc
|
0.70% |
-98.63
|
- |
- |
-
|
|
GRFS Grifols SA - ADR - Level III
|
3.00% |
14.77
|
2 |
9 |
-9%
|
|
BIIB Biogen Inc
|
0.00% |
26.14
|
- |
- |
-
|
|
AZN Astrazeneca plc - ADR
|
0.77% |
37.91
|
2 |
29 |
-12%
|
|
MRK Merck & Co Inc
Contenders
|
3.29% |
29.12
|
4 |
60 |
8%
|
|
HZNP Horizon Therapeutics Plc
|
- |
80.02
|
- |
- |
-
|
|
OGN Organon & Co.
|
- |
-
|
- |
- |
-
|
|
ABBV Abbvie Inc
Challengers
|
4.30% |
39.83
|
4 |
9 |
20%
|
|
GSK Glaxosmithkline plc - ADR
|
5.30% |
12.91
|
3 |
38 |
-1%
|
|
BAYRY Bayer Aktiengesellschaft
|
0.23% |
8.61
|
1 |
21 |
0%
|
|
RHHBY Roche Holding AG
|
0.19% |
21.47
|
1 |
18 |
2%
|
|
PFE Pfizer Inc.
Contenders
|
3.57% |
21.84
|
4 |
50 |
6%
|
|
GILD Gilead Sciences, Inc.
Challengers
|
4.01% |
286.09
|
4 |
7 |
10%
|
|
NVS Novartis AG - ADR
|
3.46% |
23.45
|
1 |
25 |
4%
|
|
BMY Bristol-Myers Squibb Co.
Contenders
|
2.80% |
-30.16
|
4 |
50 |
12%
|
|
AMGN AMGEN Inc.
Contenders
|
2.75% |
20.01
|
4 |
11 |
13%
|
|
SNY Sanofi - ADR
|
3.74% |
8.59
|
2 |
19 |
2%
|